• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2024 Scientific Session Call For Abstracts
      • 2024 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

Minimally invasive colorectal resection is associated with a temporary decrease in FGF-2 levels in both cancer and benign indication patients.

Introduction: Fibroblast growth factor-2 (FGF-2) is a promoter of endothelial cell growth and angiogenesis and, thus, plays a role in both wound healing and tumor growth. Elevated blood levels have been reported in cancer (CRC) patients prior to colorectal resection (CR) and some investigators have noted decreased levels 1 month postop. Surgery’s early impact on plasma FGF-2 levels is unknown. This study’s purpose was to determine FGF-2 levels during the first month after CR.
Methods: A total of 45 cancer and 41 benign indication patients who underwent minimally invasive CR were studied. There were no significant differences in the types of operations performed between groups. Blood samples were obtained preoperatively (preop) and on postoperative day (POD) 1 and 3 in all patients; in a fraction of patients samples were also taken between POD 7-14 or POD 15-30. FGF-2 levels were determined via ELISA; the median result in pg/ml plus the 95% confidence interval was determined for each time point. The POD 7-14 and the POD 15-30 specimens were each bundled and considered as single time points. Wilcoxon’s signed ranks test was used for analysis.
Results: The median preop level in the benign patients (18.9 pg/ml, CI 12.9-23.7) was higher than in the cancer group (13.4 pg/ml, CI 9.7-19.1, p=ns) A significant decrease in FGF-2 levels was noted on both POD 1 and 3 in both the cancer (POD1 6.5 pg/ml, CI 4.6-10.3; POD3 9.1 pg/ml, CI 5.8-15.9) and benign groups (POD1 7.3 pg/ml, CI 4.4-10.4; POD3 8.1 pg/ml, CI 6.3-10.3) when compared to preop results. Although there was no significant difference in levels at the POD 7-14 or 15-30 time points for either group, the cancer group’s values were 3-6 pg/ml lower than preop whereas the benign group’s results were very close to baseline.
Conclusions: No significant difference was noted in the preop FGF-2 levels. Surgery is associated with decreased FGF-2 levels for at least the first 3 days regardless of the indication. FGF-2 levels return to baseline in benign patients while non-significant decreases persist in the cancer patients 2-4 weeks postop. The FGF-2 decrease seen after surgery does not appear to be related to the surgical indication. The clinical significance of this short lived decrease is unclear.


Session: Poster

Program Number: P124

21

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

« Return to SAGES 2008 abstract archive

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064
1-310-437-0544
sagesweb@sages.org
Monday - Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons